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Abstract 
Mesenchymal stem or stromal cells (MSCs) act on different components of the immune 
response including macrophages (MΦs). Therefore this study has been committed to explore 
how MSCs may modify the effect of MΦ polarization upon an inductive environment using 
mouse bone marrow (BM)-derived  “naïve”, unpolarized MΦs. Phagocytosis of various M 
subtypes was different since M1 and M2b showed poorer, while M2a higher rate of 
phagocytosis. MSCs significantly promoted yeast ingestion by M1 and M2b and diminished it 
by M2a cells. Under polarizing conditions, MSCs profoundly affected the TNF production 
of M subtypes since M1 and M2b MΦs produced less and M2a produced higher amount of 
TNFwhile the amount of IL-10 was not affected The most striking effect of MSCs was 
registered on M2b cells since the inflammatory TNFdominanceremarkably shifted to the 
immunosuppressive IL-10. Prepolarized M1 cells readily converted to M2a and M2b states 
when polarizing conditions changed from M1 to M2a or M2b induction, respectively. 
Repolarizing from M1 to M2a resulted in the decline of IL-10 and TNF and defined 
elevation of Ym1 similar to levels characteristic to M2a primarily polarized from naïve BM-
Ms. Similarly, polarization of M1 to M2b MΦs was successful showing increase in IL-10 
and reduction in TNFlevels characteristic to M2b cells. However, when co-culturing with 
MSCs, M1–M2a or M1–M2b transition was not affected. Crosstalk between Ms and MSCs 
depended on PGE-2 since COX-1 and COX-2 inhibition reduced the effect of MSCs to 
establish an IL-10-dominant cytokine production by Ms. 
Introduction 
Mesenchymal stem or stromal cells (MSCs) are multipotent fibroblast-like cells that were first 
isolated from the bone marrow [1] and later identified in various tissues of the body such as 
adipose tissue, heart, liver, spleen or thymus [2, 3]. Their in vivo functions are assumed to be 
providing support for hematopoiesis, contribution to tissue maintenance and regeneration, and 
modulation of immune responses [4]. Through various soluble and cell surface molecules 
such as TGF, HGF, IL-6, PGE-2, B7-H1 or Jagged-1, they are able to communicate with a 
wide range of immune cells and usually the net outcome of these interactions is the inhibition 
of immune effector cells and the promotion of regulatory cell functions [5]. These 
characteristics make MSCs potent candidates in the treatment of inflammatory and/or 
autoimmune diseases such as acute graft versus host disease, multiple sclerosis or Crohn’s 
disease [6, 7]. 
Macrophages (MΦs) are major partakers in inflammatory and regenerative processes and thus 
in inflammation-related degenerative disorders. As opposed to our former knowledge of MΦs 
that they generally acquire an inflammatory profile, recently, several other, even suppressive 
functional phenotypes of these cells have been described after different activation stimuli [8, 
9]. “Naïve” M0 MΦs emerge from committed myeloid progenitors in the presence of M-CSF 
[10] characterized by the expression of CD11b and F4/80, a monocyte/macrophage and a 
mature MΦ marker, respectively, and readily phagocytose cellular debris or pathogens. They 
lack the expression of antigen presenting (MHC-II) and co-stimulatory (B7) molecules [10]. 
Classically activated or “M1” MΦs bear an immune phenotype of MHC-IIhiB7hi and have 
high inducible nitric oxide synthase (iNOS) activity and low chitinase (Ym1) production [11]. 
iNOS is responsible for the production of nitric oxide, a free radical with a central role in 
MΦ-mediated cytotoxicity [12]. Thus, M1 MΦs are acting as pro-inflammatory cells by 
producing large amounts of TNF, IL-1 and IL-12, performing antigen presentation towards 
adaptive immune cells, and orchestrating Th1 function [9]. Other types of MΦs, termed M2, 
are mostly antagonistic to M1 MΦs in their effect although their characteristics sometimes 
partially overlap with the pro-inflammatory phenotype [13]. Recently, subdivisions in the M2 
activation profile have arisen from different immune phenotypes and functions. Hence, 
alternatively activated, wound healing or M2a MΦs are described as MHC-IIloB7lo cells with 
low iNOS and high Ym1 activity promoting wound healing and tissue remodeling [13]. Ym1 
is a secreted chitinase-like protein with proposed pathogen-binding function and role in the 
deposition of extracellular matrix during wound-healing [14]. It serves as a good marker for 
the distinction of alternatively activated murine M2a MΦs from M1 MΦs as Ym1 is 
upregulated in the presence of Th2 cytokines serving as inductors of the phenotype [9, 11]. 
Regulatory or M2b MΦs bear an MHC-IIhiB7hi phenotype with increased iNOS activity just 
like their M1 counterparts, however, they secrete relatively low levels of pro-inflammatory 
cytokines, such as TNF and IL-12, compared to their elevated IL-10 production [13]. These 
characteristics empower M2b MΦs to be able to act as immune regulator cells favoring Th2 
activation and function and dampening pro-inflammatory responses [13, 15]. The ratio of IL-
10 to TNF or IL-12 is often used to distinguish M1 from M2 MΦs [16, 17]. Although more 
activation profiles have been identified for MΦs in vivo [18, 19], M1, M2a and M2b are the 
best described functional states. According to Edwards et al., these activation states can be 
generated in vitro by applying the appropriate inductors: TLR-ligands, such as LPS, together 
with IFN for M1, IL-4 or IL-13 for M2a and LPS together with immune complexes or 
apoptotic cells for M2b MΦ phenotypes [9, 13]. The helper T cell-derived cytokines as well 
as LPS and immune complexes are proposed to account for the in vivo physiological 
activation of MΦs into the above mentioned functionally distinct states [19]. 
Although the interaction between MSCs and T lymphocytes has been extensively studied in 
the past decades [5], the possible communication between MSCs and MΦs has only been 
gaining more attention in the last years [20, 21]. Former studies mostly focused on the 
interplay between monocytes or tissue-resident, mainly peritoneal MΦs (Pe-MΦs) and MSCs 
while the true nature of the effect of MSCs has not been profoundly elucidated on “naïve” 
(M0) MΦs. 
Therefore, in this study we have compared the purity, phenotype and response of bone 
marrow derived-Ms (BM-Ms) and Pe-Ms to the presence of MSCs. BM-Ms 
comprised of a mature, naïve, homogenous cell population while, using the standard method 
for M isolation from the mouse peritoneum based on plastic adherence [22], Pe-Ms were 
contaminated with other cells and were largely in active state. Based on the results from these 
experiments we chose BM-Ms as in vitro model system for the further studies. The 
appropriate inducing cocktails stimulated the polarization of the M0 Ms into M1, M2a and 
M2b states. Polarization of Ms into different subpopulations was differently affected by 
MSCs. The presence of MSCs resulted in the reduction of TNF both in M1 and M2b Ms 
and increase in M2a cells while no significant change in IL-10 was observed. However, the 
TNF/IL-10 ratio was remarkably shifted to the immunosuppressive IL-10 secretion only in 
the case of M0/M2b polarization. PGE-2 was identified as an important regulatory factor in 
this process.  Moreover, transition of M1 to M2a or M2b direction under changing stimulatory 
environment was successful, nevertheless, MSCs did not modify trans-polarization. 
Materials and Methods 
 
Animals 
In this study, adult (8-12 weeks old) C57Bl/6 (H-2b) mice (National Institute of Oncology, 
Budapest, Hungary) were used according to the guidelines of the Animal Care and Use 
Committee of the National Blood Service (Budapest, Hungary). 
 
Establishment and characterization of MSC cultures  
The establishment and characterization of MSC cultures was performed according to the 
methods described by Hegyi et al. [23]. Briefly, 10-12 weeks old C57Bl/6 (H-2b) mice were 
sacrificed by cervical dislocation then femurs were collected. Bone marrow (BM) cells were 
obtained by flushing out femurs with complete medium (CM) containing DMEM/Ham’s F-12 
medium (Invitrogen, Carlsbad, CA, USA), 10% fetal bovine serum, 5% horse serum 
(Invitrogen), 50 U ml-1 penicillin, 50 μg ml-1 streptomycin (Sigma-Aldrich) and 2 mM L-
glutamine (Invitrogen) supplemented with heparin at a final concentration of 5 U ml-1. The 
resulted suspension was then filtered using a 60 micron nylon mesh and washed twice with 
Hank’s balanced salt solution (HBSS) (Invitrogen). Cells were seeded in a 25 cm2 culture 
flask (BD Falcon, Bedford, MA) in CM in a density of 1-2x105 cells cm-2 and incubated in a 
humidified 5% CO2 incubator at 37˚C. After 72 hours, non-adherent cells were removed by 
replacing CM. Reaching cell confluence, primary cultures were washed with cold HBSS then 
cells were retrieved by trypsinization using 0.25% Trypsin-EDTA solution (Invitrogen) and 
seeded into 75 cm2 culture flasks (BD Falcon). Further passages were carried out by 
subculturing cells in a 1:5 ratio. Cells were used for experiments between passage 6 and 12 to 
avoid hematopoietic contamination.  
MSC characterization occurred by the analysis of their cell surface markers and 
differentiation capacity as described earlier [24]. Briefly, cells were incubated with 
monoclonal antibodies against mouse Sca-1, CD44, CD73, CD90, CD45, CD11b and Gr-1 
(all from BD Pharmingen, San Diego, CA, USA) for 20 min at 4°C in a buffer containing 
PBS with 0.5% v/w BSA. After incubation and two rounds of wash in the same buffer, 
labeling was analyzed by a FACScan flow cytometer using the CellQuest software (Becton 
Dickinson, San Diego, CA, USA). Osteogenic differentiation was induced by culturing 
confluent MSCs for 2 weeks in medium supplemented with dexamethasone (10-8 M), -
glycerophosphate (10 mM), and ascorbic acid (0.3 mM) (all from Sigma-Aldrich). To observe 
calcium deposition, cultures were stained with alizarin red S stain (Sigma-Aldrich). To induce 
adipogenic differentiation, confluent MSCs were cultured for 2 weeks in complete medium 
supplemented with dexamethasone (10-7 M) and 3-isobutyl-1-methylxanthine (0.5 mM) 
(Sigma-Aldrich). The cells were then fixed with 10% formalin and stained with oil red O 
(Sigma-Aldrich) and analyzed with microscopy. 
 
Generation of bone marrow- and peritoneal macrophages 
Bone marrow macrophages (BM-Ms) were generated by flushing the femurs of 4-8 weeks 
old mice. Then the bone marrow cells were incubated for 7 days in BM-MΦ differentiation 
medium (BMDM): CM without horse serum containing 50 ng/ml M-CSF (Miltenyi Biotec, 
Germany). Then the cells were left in BMDM without M-CSF for a further 24 hours. 
Peritoneal MΦs (Pe-MΦs) were isolated from the peritoneal cavity of 10-12 weeks old mice 
by washing the peritoneal cavity with HBSS supplemented with 10 U/ml heparin (Richter 
Gedeon, Budapest, Hungary). Peritoneal exudate cells (PEC) were washed twice with HBSS 
then seeded into 24-well flat-bottom plates (BD Falcon) and incubated for 1 hour in CM 
without horse serum in a 5% CO2 incubator at 37°C. After 1 hour, non-adherent cells were 
removed by two rounds of HBSS wash and the remaining adherent cells were used for 
experiment. 
 
Characterization of MΦs 
For characterization of Pe-MΦs and BM-MΦs by flow cytometry using FACScan instrument 
and CellQuest software (Becton Dickinson) the cells were retrieved by trypsinization (0.25% 
Trypsin-EDTA) then tested for the presence of F4/80, CD11b, MHC-II, and Ly-6c using 
fluorescein isothiocyanate (FITC)- or phycoerythrin (PE)-conjugated monoclonal antibodies 
against mouse cell surface markers (anti-F4/80 from AbD Serotec Ltd., Oxford, UK and all 
others from BD Pharmingen). Labelling occurred in dark for 20 minutes at 4°C. 
 
Induction of MΦs into different activation profiles 
Bone marrow cells (2x105 cells/well) were seeded into 24-well flat-bottom plates. For 
polarization into various M subpopulations, 100 ng/ml LPS + 10 ng/ml IFN (Miltenyi 
Biotec) were used as M1 inducers, 20 ng/ml IL-4 (Miltenyi Biotec) was used as M2a 
activator, and 100 ng/ml LPS + 100 g/ml heat-aggregated mouse IgG (IgGa) was used for 
M2b induction. Heat-aggregated mouse IgG was prepared as follows: mouse IgG1, IgG2a, 
IgG2b, and IgG3 (all from Sigma) were mixed in equal amounts, filtered through a 0.22 
micron nylon mesh and heated in a 63°C water-bath for 20 minutes. Induction was carried out 
in the presence or absence of 2x104 MSCs. For experimental setups using Pe-MΦs, 106 
PEC/well and 2x104 MSCs were used. 
 
Measurement of yeast-phagocytosis 
Heat inactivated yeast particles were added to cultures of 5x106 BM-MΦ/well or 106 Pe-
MΦs/well, and incubated for 1 hour at 37°C. After removing free yeast particles with HBSS 
wash, cells were fixed by 8% PBS-buffered formalin for 10 minutes and stained with Giemsa. 
Finally, digital photos were taken of each well by a Nikon Coolpix 4500 digital camera 
(Nikon GmbH, Düsseldorf, Germany) connected to an Olympus CK2 inverted microscope 
(Olympus, Tokio, Japan). Phagocytosis of yeast cells/macrophage was determined by 
counting ingested yeast particles in 100 macrophages then means were calculated and the 
average ingested yeast particles per one macrophage for each treatment are shown. 
 
Transwell experiments 
For transwell experiments, 2x105 BM-Ms were seeded into 24-well flat bottom plates (BD 
Falcon) and 2x104 MSCs were placed into 0.1 micron inserts (BD Falcon). Cultures were 
induced by M1, M2a or M2b activators and then incubated for 48 hours at 37°C. Finally 
culture supernatants were collected and amounts of TNFand IL-10 were analyzed as 
described below. 
 
Cytokine analysis 
Cell culture supernatants were tested for amounts of TNF, IL-10, chitinase 3-like 3 (Ym1) 
and PGE-2 using QuantikineTM mouse TNF- ELISA Kit, mouse IL-10 ELISA Kit, mouse 
CHI3L3/ECF-L ELISA Kit and ParameterTM PGE2 ELISA Kit (all from R&D Systems, Inc., 
Minneapolis, MN) according to the manufacturer’s instructions. 
For inhibition of PGE-2 synthesis 10M Resveratrol (Sigma) and/or 10M Celecoxib 
(Sigma) as COX-1 and COX-2 inhibitors, respectively were added to the cultures for 48 hours 
at 37°C then culture supernatants were collected and used for analysis of TNF and IL-10. 
For exogenous PGE-2 experiments, 200, 400 or 800 pg/ml PGE-2 (Sigma) was added to the 
cultures for 48 hours at 37°C then supernatants were collected and again levels of TNF and 
IL-10 were measured. 
 Statistical analysis 
Each graph was composed of data of three independent experiments. Significance of data was 
evaluated by two-tailed Student’s t-test with a significance level set at p<0.05. Data are 
expressed as mean ± SD. For yeast-phagocytosis, variables did not show normal distribution, 
hence the non-parametric Kruskal-Wallis test was used setting the significance level at 
p<0.05. 
Results 
 
Characterization and comparison of MΦs isolated from bone marrow and peritoneum 
Our purpose was to find the best source of Ms used for further experiments. The 
requirements included purity, and mature but inactive state. MSCs used in these experiments 
met the criteria for murine MSCs according to morphology, flow cytometry analysis of cells 
surface markers and differentiation potential (as we described earlier [24]). Treatment of bone 
marrow nucleated cells with M-CSF for one week resulted in a homogenous population of 
mature (CD11b+F4/80+) and naïve (Ly-6c-MHC-II-) MΦs (BM-Ms) (Fig. 1). In contrast, Pe-
Ms were partially activated expressing Ly-6c (11.5%) and MHC-II (71%) (Fig. 1). The 
MHC-II positive cells did not only represent activated Ms. Rather, one part of MHC-II+ 
cells belonged to CD19+ B cells (26.5±4.4%, data not shown). Additionally, Pe-M cultures 
also contained 4.8±3.1% of CD3+ T cells (data not shown). Presence of B and T cells and the 
partial appearance of cells with M markers, CD11b and F4/80, confirmed the impurity of 
the Pe-M cultures. The cells of both sources were functionally active since heat-inactivated 
yeast particles were readily phagocytosed (Fig.2A). Phagocytosis by BM-Ms and Pe-Ms 
was significantly inhibited and promoted by MSCs, respectively (Fig. 2B). Cytokine 
production of BM-Ms and Pe-Ms was also differently regulated by MSCs since they did 
not modify IL-10 and TNF production by BM-Ms while Pe-Ms secreted ~10-fold more 
of the immunosuppressive IL-10 in the presence of MSCs (Fig. 2C and D). Non-M cells and 
Ms in an already activated state could also be regulated by MSCs [25] that may hinder or 
mask the direct M response to the regulatory effect of MSCs in Pe-M cultures. All of 
these results showed that BM-derived Ms were highly superior as source of Ms as these 
cells were homogenous regarding purity and naïve, non-activated state. Therefore we used 
BM-Ms in further studies.  
  
MSCs differentially affect yeast-phagocytosis by distinct MΦ subpopulations 
M1 and M2b MΦs induced with LPS+IFN and LPS+IgGa, respectively, exerted similar 
phagocytic activity on heat-inactivated yeast while M2a, polarized with IL-4, showed 
significantly higher phagocytosis than M1 and M2b cells. The presence of MSCs differently 
affected the phagocytic activity of the various MΦ subpopulations. Hence, activity of M1 and 
M2b MΦs significantly increased while uptake by M2a declined (Fig. 3.).  
 
The presence of MSCs shifts the cytokine production of M2b cells from TNF to IL-10  
Polarization of BM-MΦs was successful as M1 and M2b cells secreted high amounts of 
TNF and IL-10 (Fig. 4A and 4B) in accordance with literature data [13]. Characteristically 
[9, 11], M2a cells lacked pronounced production of these two cytokines while producing 
substantial amounts of Ym1 (Fig. 4D). Under polarizing conditions, MSCs profoundly 
affected the TNF production of M subtypes since M1 and M2b MΦs produced less while 
M2a higher amount of TNFalthough TNF production by M2a remained at low level Fig. 
4Bwhile the amount of IL-10 was not affected (Fig. 4A) The most striking effect of MSCs 
was registered on M2b but not on M1 or M2a cells since the inflammatory TNFwas 
remarkably shifted to the immunosuppressive IL-10 (Fig.4C). In contrast, Ym1 production by 
either MΦ subpopulation was not affected by MSCs (Fig. 4D). 
 
Transition between M subpopulations is not affected by MSCs  
As Fig. 4. showed, induction of M polarization occurred upon specific culture conditions 
and MSCs enhanced the immunosuppressive properties of the M2b subpopulation, shifting 
the cytokine production to IL-10 prevalence. The question remained whether polarization 
represented a terminal differentiation of the M subpopulations or under altered 
microenvironment, the polarization might shift toward another polarization state and MSCs 
could modify this process. To resolve this question, prepolarized M1 Ms were created and 
placed into a distinct polarizing stimulation with or without being co-cultured with MSCs. 
During M1–M2a transition, IL-10 and TNF production was highly reduced while Ym1 level 
was remarkably increased (Fig. 5A). Contrarily, during M2b polarization from M1 cells, IL-
10 highly increased and TNF- strongly diminished while Ym1 remained at a very low level 
(Fig. 5B). Both transition directions from M1 cells indicated that under altered polarizing 
environment, M1 cells cordially transformed to M2a or M2b Ms. Polarization of M1 to M2b 
also occurred generating an IL-10 predominance, however, MSCs did not affect the levels of 
IL-10 or TNF (Fig. 5B) as it was observed for M0–M2b transition (Fig. 4). The reason for 
the absence of any effect by MSCs could be accounted for the very low TNF production in 
the absence of MSCs that could not be further reduced. 
 
Requirement of PGE-2 in regulation of M functions by MSCs  
Cross-talk between MSCs and MΦs may occur by direct cell-cell interaction and/or by 
soluble factors. To analyze this question a transwell system was applied. The physical 
separation of MSCs and MΦs did not affect IL-10 (Fig. 6A) or TNF production (Fig. 6B) 
indicating the role of soluble factors in the process. 
As shown on Fig. 4, M2b cells responded most profoundly to MSCs by shifting their cytokine 
production from TNF to IL-10. To determine whether an important MSC-derived 
immunoregulatory factor PGE-2 [26] plays a role in the modulation of M2b polarization, 
PGE-2 production has been inhibited in M2b–MSC cocultures (Fig. 7A). Resveratrol, a COX-
1 inhibitor did not influence, while the COX-2 inhibitor Celecoxib or the combination of 
COX-1 and COX-2 inhibitors shifted the cytokine production of M2b MΦs to TNF.  
To affirm the role of PGE-2 in the MSC–M2b MΦ interaction, MSCs were replaced with 
different concentrations of PGE-2 (Fig. 7B). The addition of PGE-2 shifted the TNF/IL-10 
ratio of M2b MΦs towards IL-10 in a concentration-dependent manner confirming its major 
role in the effect of MSCs on M2b MΦs. Hence, PGE-2 was found to be an important soluble 
factor in the MMSC interaction. 
 
Discussion 
Orchestrated macrophage activation and function during inflammation initiation, resolution 
and subsequent reparative processes are key events in responding to challenge and returning 
to homeostasis. Numerous pathological conditions show impaired M response [27-29], 
hence targeting Ms with MSC therapy can be of great importance. However, the effect of 
MSCs on M functions has not clearly been explored yet. So far, the majority of studies have 
used adherent cells from peritoneal exudates or spleen isolates [30, 31]. Using the standard 
method for M isolation from the mouse peritoneum based on plastic adherence [22], these 
cultures contain at least 5-10% of non-M cells [25, 32] and these contaminating cells may 
also be affected by MSCs masking the M response or modifying the results of co-culture 
experiments. Also the isolated Ms might have acquired an unknown fate in vivo in the past, 
hence, these cultures likely contain different unrecognized subpopulations of Ms in different 
activation states that may affect the conclusions drawn from the results. Moreover, certain 
tissue resident MΦ populations, such as Pe-MΦs, have recently been recognized as mostly 
consisting of a self-renewing, embryonic-yolk-sac-derived cell population, and therefore can 
differ from the continuously forming, monocyte-derived MΦs [33, 34]. Indeed, comparing 
BM- and Pe-Ms, we found that while Ms from bone marrow were a homogenous 
population of naïve cells with mature M phenotype, Pe-Ms were contaminated with non-
M cells and showed a remarkable activated status. Moreover, Pe-Ms responded with 
highly elevated IL-10 production to the presence of MSCs supporting that PEC contained 
MSC-responsive non-M cells even after 1 hour of plating while BM-Ms did not secrete 
increased amount of this immunosuppressive cytokine. To avoid the above disadvantages, we 
have applied BM-MΦs. Appropriate inducing cocktails triggered the generation of MΦ 
subpopulations, M1, M2a and M2b [13, 17, 35]. This model has been used to answer two 
major questions: 1) how MSCs may modify the effect of an inductive environment; 2) 
whether the shift from one to another MΦ polarization state induced by the instantaneous 
microenvironment represents an irreversible or a reversible process. 
As shown, the various M subtypes were distinguishable in their phagocytic capacity since 
M1 and M2b showed poorer, while M2a higher phagocytosis. This function was modified by 
MSCs since yeast ingestion by M1 and M2b was elevated while it was decreased for M2a 
Ms. To date, most of our knowledge regarding phagocytic capacity as well as phagosome 
maturation concerns M1 and M2a Ms [36]. Recent works showed slower phagosome 
maturation for M1 than M2a Ms [36] serving as an explanation for the delayed particle 
uptake by M1 compared to M2a macrophages. Increased zymosan and apoptotic thymocyte 
phagocytosis by mouse Ms in the presence of MSCs was described by Maggini et al. [30]. 
The mechanism of this effect, however, is unclear and need further investigation. The 
functional changes during the induction of M subpopulations were reflected in the 
alterations in the production of different factors: M1 and M2b polarization resulted in 
remarkable rise of IL-10 and TNFcytokines that were not secreted by naive Ms, while the 
level of these factors did not change in M2a cultures. Moreover, chitinase (Ym1) expression 
found only in M2a cells [9] increased to a high level under M2a polarizing conditions. These 
results were in accordance with previous data [37]. The presence of MSCs did not cause a 
change in the level of IL-10 or Ym1, however significantly downregulated TNF in M1 and 
M2b cells and upregulated in M2a Ms although to a very low level. Tumor growth factor 
beta 1 (TGF-1), another potent immunosuppressive molecule produced by both MΦs [38] 
and MSCs [39] was also analyzed in the MSC–MΦ interaction, however, none of the MΦ 
subsets responded with changes in TGF-1 when cocultured with MSCs (data not shown). 
The most important consequence of the presence of MSCs was their effect on the ratio of 
TNF/IL-10 in M2b cells since cytokine production shifted toward the immunosuppressive 
IL-10. An emerging dogma in regenerative biology suggests that M1 MΦs are the 
predominant population being present during the first few days after injury, corresponding to 
the early inflammatory and proliferative phases, whereas alternatively activated MΦs, M2a 
and M2b, are the main effectors of the later stages of tissue repair and remodeling [27]. 
Accordingly, M1 cells readily transformed into M2a or M2b cells when changing the 
microenvironment. Interestingly, MSCs did not affect the cytokine production by M2b cells 
transformed from M1. A plausible explanation for this finding is that during M1 to M2b 
polarization, TNF level is dramatically reduced and MSCs that primarily act on TNF 
production are not able to further reduce this cytokine. This decline of TNF may stem from 
endotoxin tolerance [40] since both M1 and M2b polarization is induced partially with LPS. 
The second LPS stimulation can inhibit TNF expression [41]. It is also apparent from our 
results that the presence of MSCs is permissive for TNF production although in diminished 
quantities. Certain amounts of TNF, and a controlled, dynamic change in TNF/IL-10 levels 
seem to play important roles in regenerative physiological processes. Anti-inflammatory and 
proinflammatory cytokine expression, however, may be induced simultaneously at early time 
points during tissue repair. For example, at 48h after acute liver injury in mice, MΦs 
simultaneously express IL-10 and TNF. During skeletal muscle repair, satellite cells are 
major targets of TNFα signaling that promotes the early proliferative stage of myogenesis 
[43]. In the case of heart, TNFα has a cardioprotective function in mice [44]. On the other 
hand, mononuclear phagocytes engage in a bidirectional interaction with MSCs [20]. MΦ-
derived TNFis able to induce tumor necrosis factor alpha-stimulated gene 6 (TSG6) 
production by MSCs. The secreted TSG6 is one of the most important, MSC-derived soluble 
mediator with anti-inflammatory and immunosuppressive activity in vitro, as well as in vivo 
[45]. It is also important to note that changes in the cytokine levels we measured reflect 
alterations in the activation of MΦs only as several laboratories proved that MSCs are not 
capable of producing IL-10 [46] or TNF even after treatment with TLR agonists [47]. In 
accordance with these findings, we could not detect TNF and IL-10 production in MSC 
control wells even when LPS or IFN was present. In another work of our laboratory, we also 
proved that MSCs do not produce either of these cytokines when cocultured with microglial 
cells, another type of macrophage, using transwell coculturing systems [48]. Thus, activation 
of the TNF or IL-10 promoter in MSCs in the presence of macrophages is highly unlikely.  
In agreement with several earlier results [21, 49, 50], the crosstalk between Ms and MSCs 
occur primarily by soluble factors, since cytokine production during physical separation of the 
two cell types was similar to those measured in direct co-cultures. One of the soluble factors 
produced by both Ms and MSCs is PGE-2. The immunologically relevant synthesis of PGE-
2 depends mostly on COX-2 but not COX-1 enzyme activity with COX-2 being the inducible 
and COX-1 the constitutively active isoforms [51]. Our results support these literature data, 
since the inhibition of COX-2 but not COX-1 resulted in a shift of cytokine production 
towards TNFin our M2b M–MSC cocultures. The importance of PGE-2 in the cross-talk 
between Ms and MSCs was further affirmed when exogenous PGE-2 was added to M2b 
cells instead of MSCs and PGE-2 acted similarly to MSCs on M2b cells. These results 
indicate that PGE-2 plays a pivotal role in MSC-modified M polarization, as already shown 
by several other laboratories [30, 52, 53]. Although extensive in vivo studies are needed to 
further verify in vitro results, in the light of these findings, MSCs seem to be promising 
candidates for the manipulation of MΦ polarization towards a more M2b-like, IL-10-
dominant immunosuppressive phenotype during tissue regeneration and in the treatment of 
various inflammatory and/or autoimmune diseases. 
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Figure legends 
Fig. 1. Characterization of bone marrow- and peritoneal cavity-derived MΦs. The 
expression of monocyte-macrophage marker CD11b, mature macrophage marker F4/80, and 
MΦ activation markers MHC-II and Ly-6c were measured on BM- and Pe-Ms using flow 
cytometry. Light grey shaded histograms and continuous lines represent the results given by 
isotype matched controls and the indicated specific antibodies, respectively.  
 
Fig. 2. Comparison of functions of BM- and Pe-Ms. (A) MΦs phagocytosing yeast 
particles for one hour were fixed then stained with Giemsa and analyzed with light 
microscopy.(B) The number of ingested yeast particles per MΦ were counted using light 
microscopy images of Giemsa stained cultures and was evaluated in at least 100 Ms per 
treatment. Results are representative of three independent experiments and are shown as mean 
± SE. (C) The amount of IL-10 and (D) TNF secreted by BM- or Pe-Ms in the presence or 
absence of MSCs was measured using ELISA assays. Results are shown as mean ± SD, n=3. 
   
Figure 3. Yeast ingestion by M1, M2a or M2b polarized BM-MΦs. MΦs were induced 
with M1, M2a or M2b medium in the presence or absence of MSCs and yeast ingestion was 
analyzed as described under Fig 2B. Results are shown as mean ± SD, n=3. 
 
Figure 4. Cytokine analysis of MΦs subpopulations. Supernatants harvested from polarized 
M1, M2a and M2b MΦ cultures after 48 hours of induction of polarization were used the 
detect the concentrations of IL-10 (A), TNF, (B) and Ym1 (D) using ELISA. Results are 
expressed as mean ± SD, NS: not significant, n=3. The relative TNF/IL-10 ratio (C) was 
calculated compared with TNF/IL-10 ratio in MΦ-only cultures that is represented as one. 
 
Figure 5. Trans-polarization of M1 cells to M2a or M2b.  Naïve M0 MΦs were treated 
with M1, M2a or M2b inducing agents (A and B) in the presence or absence of MSCs for 48 
hours (A and B). For M1-M2a (A) and M1-M2b (B) transitions,  prepolarized M1 cells were 
washed twice with HBSS and media were replaced with CM containing either M2a (A) or 
M2b (B) inducing cocktails with or without MSCs. After 48 hours of incubation, supernatants 
were collected and concentrations of IL-10, TNF and Ym1 were analyzed with ELISA. 
Results are expressed as mean ± SD, n=3; NS, not significant.  
 
Figure 6. Physical separation of MSCs and MΦs in transwell system. One micron pore-
sized transwell chambers were used to inhibit direct MΦ-MSC interaction. Ms were seeded 
into 24-well flat bottom plates and polarized with the appropriate inductors while MSCs were 
placed in the transwell chambers. Cell culture supernatants were collected after 48 hours of 
incubation. IL-10 (A) and TNF (B) concentrations were measured with ELISA. Results are 
expressed as mean ± SD, n=3; NS, not significant. 
 
Figure 7. Role of PGE-2 in the establishment of TNF/IL-10 ratio by M2b MΦs. (A) 
Ms and MSCs were cocultured in M2b inducing medium in the absence or presence of 
cyclooxigenase inhibitors, 10M Resveratrol (COX-1) and/or 10M Celecoxib (COX-2) for 
48 hours. (B) MΦs in M2b medium were either cocultured with MSCs or treated with 200, 
400 or 800 pg/ml PGE-2 for 48 hours. TNF and IL-10 concentration in the culture 
supernatants were measured using ELISA assays. The relative TNF/IL-10 ratio was 
calculated in proportion to TNF/IL-10 ratio in MΦ–MSC cocultures with no inhibitors that 
is represented as one (A), or in proportion to TNF/IL-10 ratio in MΦ-only cultures that is 
represented as one (B), respectively. Results are expressed as mean ± SD, n=3; NS, not 
significant. 
